Yayınlar & Eserler

Yayın Ağı
Makaleler 24
Tümü (24)
SCI-E, SSCI, AHCI (20)
SCI-E, SSCI, AHCI, ESCI (21)
ESCI (1)
Scopus (22)
TRDizin (2)
Diğer Yayınlar (1)

1. FDA original new drug approvals in the first quarter of 2025

Ertan-Ahmed S., Çapan Y., Şahin A.
European Journal of Life Sciences , cilt.4, sa.2, ss.94-105, 2025 (Hakemli Dergi)

2. Latest developments in small molecule analgesics: heterocyclic scaffolds II

EVREN A. E., HIDIR A., Kurban B., Özkan B. N. S., LEVENT S., ŞAHİN A., et al.
Future Medicinal Chemistry , cilt.17, sa.19, ss.2391-2405, 2025 (SCI-Expanded, Scopus) identifier identifier

3. ICP-MS Method for Simultaneous Determination of Aluminum, Sodium, and Potassium in Human Albumin Solution for Infusion

Gundogdu S. O., Aytimur Y., Turhan S., ŞAHİN A.
International Journal of Analytical Chemistry , cilt.2025, sa.1, 2025 (SCI-Expanded, Scopus) identifier identifier

4. An all-in-one nanoparticle for overcoming drug resistance: doxorubicin and elacridar co-loaded folate receptor targeted PLGA/MSN hybrid nanoparticles.

Tonbul H., Şahin A., Öztürk S. C., Ultav G., Tavukçuoğlu E., Akbaş S., et al.
Journal of drug targeting , cilt.32, sa.9, ss.1101-1110, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

5. Development and In Vitro Evaluation of Quercetin Loaded Folic Acid Conjugated PLGA Nanoparticles for the Treatment of Breast Cancer

Çetiner K., Seko I., Ulutürk S., Gür B., Şahin A., Çapan Y.
ACTA FARMACEUTICA BONAERENSE , cilt.43, sa.10, ss.2177-2183, 2024 (SCI-Expanded)

6. DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR DETERMINATION OF ELEMENTAL IMPURITIES IN MICAFUNGIN FOR INJECTION

Gundogdu S. O., Turhan S., Babacanoglu A. O., Catak T., ŞAHİN A.
Acta Poloniae Pharmaceutica - Drug Research , cilt.81, sa.2, ss.279-286, 2024 (SCI-Expanded, Scopus) identifier identifier

7. Thermosensitive gel of pomegranate peel extract as alternative for the treatment of local infections

ŞAHİN A., GÜL Ü. D., Bayazit G., KAYNAK M. S.
Acta Pharmaceutica Sciencia , cilt.62, sa.3, ss.647-659, 2024 (Scopus) identifier

8. Targeted siRNA lipid nanoparticles for the treatment of KRAS-mutant tumors

Anthiya S., ÖZTÜRK S. C., Yanik H., Tavukcuoglu E., ŞAHİN A., Datta D., et al.
Journal of Controlled Release , cilt.357, ss.67-83, 2023 (SCI-Expanded, Scopus) identifier identifier

9. Comparative evaluation of lyophilized voriconazole formulations marketed in European Union

ŞAHİN A., Çilingiroğlu G. Y., Çatak T., Ulusoy S., GÜL Ü. D., Gündoğdu S. Ö.
Journal of Research in Pharmacy , cilt.27, sa.1, ss.120-129, 2023 (ESCI, Scopus, TRDizin) Creative Commons License identifier

10. Silica nanoparticle synthesis by experimental design for drug and gene delivery applications

Ultav G., TONBUL H., ŞAHİN A., ÇAPAN Y.
Journal of Research in Pharmacy , cilt.27, sa.1, ss.12-22, 2023 (Scopus, TRDizin) Creative Commons License identifier identifier

11. Intraperitoneal administration of PLGA nanoparticles could deliver the cargo to tumor-associated macrophages with less spreading peritoneal macrophages in the treatment of peritoneal carcinomatosis

ŞAHİN A., ÖZTÜRK S. C.
Journal of Drug Delivery Science and Technology , cilt.77, 2022 (SCI-Expanded, Scopus) identifier

12. Evaluation of burn wound healing activity of thermosensitive gel and PLGA nanoparticle formulation of quercetin in Wistar albino rats

Cetin N., Menevse E., Celik Z. E., Ceylan C., Rama S. T., Gultekin Y., et al.
Journal of Drug Delivery Science and Technology , cilt.75, 2022 (SCI-Expanded, Scopus) identifier

13. Development of curcumin and docetaxel co-loaded actively targeted PLGA nanoparticles to overcome blood brain barrier

Seko I., TONBUL H., Tavukcuoglu E., Sahin A., Akbas S., Yanik H., et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , cilt.66, 2021 (SCI-Expanded, Scopus) identifier identifier

14. Folic acid decoration of mesoporous silica nanoparticles to increase cellular uptake and cytotoxic activity of doxorubicin in human breast cancer cells

TONBUL H., Sahin A., Tavukcuoglu E., Ultav G., AKBAŞ S., AKTAŞ Y., et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , cilt.63, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

15. pH-sensitive chitosan-PEG-decorated hollow mesoporous silica nanoparticles could be an effective treatment for acute myeloid leukemia (AML)

Ultav G., TONBUL H., Tavukcuoglu E., ÖZTÜRK S., Akbas S., Sahin A., et al.
Journal of Nanoparticle Research , cilt.24, sa.2, 2021 (SCI-Expanded, Scopus) identifier identifier

16. Combination of Paclitaxel and R-flurbiprofen loaded PLGA nanoparticles suppresses glioblastoma growth on systemic administration

Caban-Toktas S., Sahin A., Lule S., Esendagli G., Vural I., Karlı Oguz K., et al.
International Journal of Pharmaceutics , cilt.578, 2020 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

17. Combination drug delivery with actively-targeted PLGA nanoparticles to overcome multidrug resistance in breast cancer

Tonbul H., Sahin A., Tavukcuoglu E., ESENDAĞLI G., ÇAPAN Y.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , cilt.54, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

18. Characterization of bevacizumab by dynamic light scattering while maintaining its native structure

Akbas S., Sahin A., ÇALIŞ S., Oncel H., ÇAPAN Y.
PHARMAZIE , cilt.73, sa.7, ss.369-374, 2018 (SCI-Expanded, Scopus) identifier identifier identifier

19. Development and in vitro evaluation of doxorubicin and celecoxib co-loaded bone targeted nanoparticles

Kozlu S., Sahin A., Ultav G., Yerlikaya F., ÇALIŞ S., ÇAPAN Y.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , cilt.45, ss.213-219, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

20. Design and in vitro evaluation of tenofovir-loaded vaginal gels for the prevention of HIV infections

TİMUR S. S., ŞAHİN A., AYTEKİN E., ÖZTÜRK N., Polat K. H., Tezel N., et al.
Pharmaceutical Development and Technology , cilt.23, sa.3, ss.301-310, 2018 (SCI-Expanded, Scopus) identifier identifier

21. Development and validation of a LC-FL method for the simultaneous determination of doxorubicin and celecoxib in nanoparticulate fixed dose combination (NanoFDC)

Kozlu S., ŞAHİN A., ÇALIŞ S., ÇAPAN Y.
PHARMAZIE , cilt.72, sa.10, ss.568-570, 2017 (SCI-Expanded, Scopus) identifier identifier identifier

22. Evaluation of brain-targeted chitosan nanoparticles through blood-brain barrier cerebral microvessel endothelial cells

Sahin A., Yoyen-Ermis D., Caban-Toktas S., Horzum U., AKTAŞ Y., Couvreur P., et al.
JOURNAL OF MICROENCAPSULATION , cilt.34, sa.7, ss.659-666, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

23. A small variation in average particle size of PLGA nanoparticles prepared by nanoprecipitation leads to considerable change in nanoparticles' characteristics and efficacy of intracellular delivery

ŞAHİN A., ESENDAĞLI G., YERLİKAYA F., Caban-Toktas S., Yoyen-Ermis D., HORZUM U., et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY , cilt.45, sa.8, ss.1657-1664, 2017 (SCI-Expanded, Scopus) identifier identifier identifier

24. Using PVA and TPGS as combined emulsifier in nanoprecipitation method improves characteristics and anticancer activity of ibuprofen loaded PLGA nanoparticles

Sahin A., Spiroux F., Guedon I., Arslan F., Sarcan E., Ozkan T., et al.
Pharmazie , cilt.72, sa.9, ss.525-528, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier
Kitaplar 4

1. Overcoming the challenges of drug resistance through combination drug delivery approach

TONBUL H., ŞAHİN A., ÇAPAN Y.
Combination Drug Delivery Approach as an Effective Therapy for Various Diseases, Elsevier, ss.31-46, 2022 identifier

2. Drug Delivery with Targeted Nanoparticles: In Vitro and in Vivo Evaluation Methods

ÇAPAN Y., ŞAHİN A., TONBUL H.
Taylor & Francis Ltd, 2021 identifier

3. Clinical Trials of Targeted Nanoparticulate Drug Delivery Systems

ŞAHİN A., Ceylan C., Ertan-Ahmed S.
Drug Delivery with Targeted Nanoparticles: In Vitro and in Vivo Evaluation Methods, Taylor & Francis Ltd, ss.615-642, 2021 identifier

4. Regulatory Guidelines of the US Food and Drug Administration and the European Medicines Agency for Actively Targeted Nanomedicines

Çetintaş H. C., TONBUL H., ŞAHİN A., ÇAPAN Y.
Drug Delivery with Targeted Nanoparticles: In Vitro and in Vivo Evaluation Methods, Taylor & Francis Ltd, ss.725-741, 2021 identifier
Metrikler

Yayın

29

Yayın (WoS)

22

Yayın (Scopus)

27

Atıf (Scopus)

507

H-İndeks (Scopus)

11

Fikri Mülkiyet

5

Tez Danışmanlığı

1

Açık Erişim

3
BM Sürdürülebilir Kalkınma Amaçları